Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Séverine Margeridon"'
Autor:
Madhumita Ramesh, Todd Warczak, Nyaradzo Dzvova, Raymond Abayan, Maria Gencoglu, Thea Riel, Anthony Henriquez, Preetha Markose, Kristin Loomis, Olga Mikhaylichenko, Nathan Hendel, Eric Hall, Richard Dannebaum, Séverine Margeridon, Monica Herrera
Publikováno v:
Genetics in Medicine Open, Vol 1, Iss 1, Pp 100682- (2023)
Externí odkaz:
https://doaj.org/article/7a283fc7ce3648889d18ff5cf41848b5
Autor:
Thu-Hoa Tran-Thi, Séverine Margeridon-Thermet, Guillaume Le Chevallier, Romain Francois, Laurent Mugherli, Frédéric Hammel, Charles Rivron, Farhad Abedini
Publikováno v:
Photoniques. :28-33
Le formaldehyde est le principal polluant de l’air interieur. Du fait de sa presence ubiquiste liee aux nombreuses sources d’emission, la teneur de ce polluant nocif dans l’air interieur est representative d’une bonne ou d’une mauvaise qual
Autor:
Sandra Carrouée-Durantel, Fabien Zoulim, Luc Barraud, Christian Trepo, Alan Kay, Isabelle Chemin, Séverine Margeridon
Publikováno v:
Antimicrobial Agents and Chemotherapy. 52:3068-3073
Complete characterization of the biological properties of hepatitis B virus (HBV) variants requires the generation of full-length genomes. The aim of this study was to develop new tools for the efficient full-length genome amplification of virus from
Publikováno v:
Journal of General Virology. 86:1687-1693
Hepatitis B virus (HBV) infections can be prevented or controlled by the host humoral immune response (anti-HBs) directed against the major surface antigen (HBsAg), elicited either naturally or by vaccination. A chronic HBV carrier was found to have
Publikováno v:
Hepatology
Hepatology, Wiley-Blackwell, 2006, 43 (1), 195; author reply 195-196. ⟨10.1002/hep.21008⟩
Hepatology, Wiley-Blackwell, 2006, 43 (1), 195; author reply 195-196. ⟨10.1002/hep.21008⟩
International audience
Publikováno v:
Viruses, Vol 2, Iss 12, Pp 2696-2739 (2010)
Human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) are the most prevalent deadly chronic viral diseases. HIV is treated by small molecule inhibitors. HBV is treated by immunomodulation and small molecule inhibito
Externí odkaz:
https://doaj.org/article/88eeba684a174a7ea825914ac3401664
Autor:
Severine Margeridon-Thermet, Sophie Le Pogam, Lewyn Li, Tommy F Liu, Nancy Shulman, Robert W Shafer, Isabel Najera
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105569 (2014)
Hepatitis C virus (HCV) variants that confer resistance to direct-acting-antiviral agents (DAA) have been detected by standard sequencing technology in genotype (G) 1 viruses from DAA-naive patients. It has recently been shown that virological respon
Externí odkaz:
https://doaj.org/article/c67099558ba645a4bc5adaefcca5165e